Brickell Biotech, Inc. (BBI) financial statements (2022 and earlier)

Company profile

Business Address 5777 CENTRAL AVENUE
BOULDER, CO 80301
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:26,88430,11511,70048,07160,49935,62136,708
Cash and cash equivalents26,88430,1157,23211,87024,8415,06913,450
Short-term investments  4,49736,20135,65830,55223,258
Other undisclosed cash, cash equivalents, and short-term investments  (29)    
Restricted cash and investments    1923,3113,246
Receivables   1,1285,1248,9354,544
Deferred costs    10,502  
Other undisclosed current assets2,7163,4156,269    
Total current assets:29,60033,53017,96949,19976,31747,86744,498
Noncurrent Assets
Operating lease, right-of-use asset5974159
Property, plant and equipment5830161006061,1731,873
Long-term investments and receivables   2,3862,2092,0462,052
Long-term investments   2,3862,2092,0462,052
Intangible assets, net (including goodwill)    7038101,300
Intangible assets, net (excluding goodwill)    7038101,300
Other noncurrent assets   659659388191
Total noncurrent assets:1171041753,1454,1774,4175,416
TOTAL ASSETS:29,71733,63418,14452,34480,49452,28449,914
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4,7415,9888,6243,5515,2174,1273,912
Accounts payable1,6055682,2454121,213326733
Accrued liabilities3,1365,4206,379371333614361
Employee-related liabilities   1,7682,6542,5182,220
Other undisclosed accounts payable and accrued liabilities   1,0001,017669598
Deferred revenue  1,795
Debt 29178    
Deferred revenue and credits11,7003,018250
Contract with customer, liability30
Other undisclosed current liabilities6974     
Total current liabilities:4,8106,35310,4973,58116,9177,1454,162
Noncurrent Liabilities
Long-term debt and lease obligation 14673    
Long-term debt, excluding current maturities 146     
Operating lease, liability  73
Liabilities, other than long-term debt      359
Deferred revenue and credits  359
Total noncurrent liabilities: 14673   359
Total liabilities:4,8106,49910,5703,58116,9177,1454,521
Stockholders' equity
Stockholders' equity attributable to parent24,90727,1357,57448,76363,57745,13945,393
Common stock1,19453685218218111915
Additional paid in capital169,080132,49292,497490,337489,975458,881449,343
Accumulated other comprehensive income (loss)  (28)2721222540
Accumulated deficit(145,367)(105,893)(84,980)(442,064)(426,738)(413,878)(404,905)
Total stockholders' equity:24,90727,1357,57448,76363,57745,13945,393
TOTAL LIABILITIES AND EQUITY:29,71733,63418,14452,34480,49452,28449,914

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues4041,8227,9171,62213,81914,53120,950
Revenue, net13,40112,80418,860
Cost of revenue   (2,231)(6,479)(6,291)(10,927)
Cost of goods and services sold   (1,436)(6,479)(6,291)(10,927)
Gross profit:4041,8227,917(609)7,3408,24010,023
Operating expenses(40,648)(22,798)(32,385)(19,037)(20,726)(17,417)(30,354)
Other undisclosed operating income      10,927
Operating loss:(40,244)(20,976)(24,468)(19,646)(13,386)(9,177)(9,404)
Nonoperating income839631573,392426204166
Investment income, nonoperating83963157    
Interest and debt expense(69) 222    
Net loss:(39,474)(20,913)(24,089)(16,254)(12,960)(8,973)(9,238)
Other undisclosed net income attributable to parent  212    
Net loss attributable to parent:(39,474)(20,913)(23,877)(16,254)(12,960)(8,973)(9,238)
Preferred stock dividends and other adjustments  10,274    
Net loss available to common stockholders, diluted:(39,474)(20,913)(13,603)(16,254)(12,960)(8,973)(9,238)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(39,474)(20,913)(24,089)(16,254)(12,960)(8,973)(9,238)
Other comprehensive income (loss)2,263  15097(15)52
Comprehensive loss:(37,211)(20,913)(24,089)(16,104)(12,863)(8,988)(9,186)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2,263)28184    
Comprehensive loss, net of tax, attributable to parent:(39,474)(20,885)(23,905)(16,104)(12,863)(8,988)(9,186)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: